Ratings Omega Healthcare Investors, Inc.

Equities

OHI

US6819361006

Market Closed - Nyse Other stock markets 04:00:01 2023-12-08 pm EST			5-day change	1st Jan Change
30.52 ^USD	-0.03%		-4.98%	+9.19%

Nov. 27	Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $33 From $34, Maintains Equal-Weight Rating	MT
Nov. 07	North American Morning Briefing : Higher Bond -2-	DJ

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The group's activity appears highly profitable thanks to its outperforming net margins.
This company will be of major interest to investors in search of a high dividend stock.
Analyst opinion has improved significantly over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The firm trades with high earnings multiples: 27.56 times its 2023 earnings per share.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector : Specialized REITs

	1st Jan change	Capi.	ESG Refinitiv
OMEGA HEALTHCARE INVESTORS, INC.	+9.19%	7 477 M $	B
WELLTOWER INC.	+33.82%	48 550 M $	A-
VENTAS, INC.	+3.71%	18 786 M $	A-
HEALTHPEAK PROPERTIES, INC.	-25.21%	10 258 M $	A
HEALTHCARE REALTY TRUST INCORPORATED	-18.47%	6 048 M $	B-
SABRA HEALTH CARE REIT, INC.	+13.76%	3 269 M $	C+
AEDIFICA SA	-18.14%	3 172 M $	B+
PHYSICIANS REALTY TRUST	-13.13%	2 993 M $	B+
MEDICAL PROPERTIES TRUST, INC.	-57.90%	2 807 M $	C
COFINIMMO	-17.20%	2 738 M $	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes